findmyKOL

Alberto Espay, MD

Enriched profile

Professor of Clinical Neurology; Division Director and Research Endowed Chair, James J. and Joan A. Gardner Family Center for Parkinson's Disease and Movement Disorders · University of Cincinnati

ORCID↗NPI↗
✓ Full profile
Region🇺🇸 Cincinnati, OH · Midwest · United StatesSpecialtyNeurologyFocusParkinson's Disease Mechanisms and Treatments+4
Active KOLfindmyKOL type: EliteLatest publication2026Online presenceverified 2026Payments2021–2025NIH funding2011–2015

Alberto Espay is Professor of Clinical Neurology; Division Director and Research Endowed Chair, James J. and Joan A. Gardner Family Center for Parkinson's Disease and Movement Disorders at University of Cincinnati. OpenAlex indexes 752 publications with 23,940 citations (h-index 82); ClinicalTrials.gov lists 5 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 10% of Neurology profiles in the findmyKOL directory.

Data verified 14 Aug 2026

Overview

Updated 14 Oct 2026

Alberto Espay, MD, is Professor of Clinical Neurology at University of Cincinnati, Department of Neurology & Rehabilitation Medicine. The public record shows 752 publications with 23,940 citations (h-index 82), centered on Parkinson's Disease Mechanisms and Treatments, Neurological disorders and treatments, Genetic Neurodegenerative Diseases. It also documents an investigator role on 5 registered clinical trials, industry payments reported by 20 companies, 1 NIH-funded awards (2011–2015).

  • Most recent indexed publication: 2026 · Journal of Parkinson's disease
  • Top research focus: Parkinson's Disease Mechanisms and Treatments
  • 5 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 20 companies

Generated from the cited public record · current as of 14 Oct 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Parkinson's Disease4 trialsDystonia1 trialTorticollis1 trial

Research focus

OpenAlex concept fingerprint
Parkinson's Disease Mechanisms and TreatmentsNeurological disorders and treatmentsGenetic Neurodegenerative DiseasesBotulinum Toxin and Related Neurological DisordersParkinson's Disease and Spinal Disorders

Drugs & molecules

across trials, industry payments and publications
Apokyngeneric · ApomorphineClinical trials—Industry payments29Publications1Gocovrigeneric · AmantadineClinical trials—Industry payments7Publications1Nuplazidgeneric · PimavanserinClinical trials—Industry payments2Publications1Crexontgeneric · Carbidopa / levodopaClinical trials—Industry payments60Publications—Botoxgeneric · Botulinum toxin type AClinical trials—Industry payments16Publications—Quliptageneric · AtogepantClinical trials—Industry payments7Publications—Ubrelvygeneric · UbrogepantClinical trials—Industry payments4Publications—Ingrezzageneric · ValbenazineClinical trials—Industry payments3Publications—DeutetrabenazineClinical trials—Industry payments2Publications—GlycopyrroniumClinical trials—Industry payments2Publications—Ongentysgeneric · OpicaponeClinical trials—Industry payments2Publications—Leqembigeneric · LecanemabClinical trials—Industry payments1Publications—

Works with

trial sponsors and companies reporting payments
MDD US Operations, LLCClinical trials—Industry payments79Amneal Pharmaceuticals LLCClinical trials—Industry payments67Abbvie Inc.Clinical trials—Industry payments41Mitsubishi Tanabe Pharma America, Inc.Clinical trials—Industry payments26Merz Pharmaceuticals, LLCClinical trials—Industry payments5Sunovion Pharmaceuticals Inc.Clinical trials—Industry payments5Abbott LaboratoriesClinical trials—Industry payments4Avion PharmaceuticalsClinical trials—Industry payments4Neurocrine Biosciences, Inc.Clinical trials—Industry payments3Teva Pharmaceuticals USA, Inc.Clinical trials—Industry payments3University of CincinnatiClinical trials3Industry payments—ACADIA Pharmaceuticals IncClinical trials—Industry payments2Acorda Therapeutics, IncClinical trials—Industry payments2Medtronic, Inc.Clinical trials—Industry payments2Boston Scientific CorporationClinical trials—Industry payments1Eisai Inc.Clinical trials—Industry payments1InSightec,IncClinical trials—Industry payments1Ipsen Biopharmaceuticals, IncClinical trials—Industry payments1Kyowa Kirin Co., LtdClinical trials—Industry payments1Kyowa Kirin, Inc.Clinical trials—Industry payments1Michael J. Fox Foundation for Parkinson's ResearchClinical trials1Industry payments—NeuroDerm Ltd.Clinical trials1Industry payments—Tanabe Pharma America, Inc.Clinical trials—Industry payments1

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
752publications

Distinct works indexed by OpenAlex, matched via ORCID; 104 in PubMed.

23,940citations

Total citations across indexed works.

82h-index

Hirsch index (OpenAlex). i10-index 316.

Clinical & industry

trials, payments and federal funding
5clinical trials

Investigator role on registered studies.

View trials ↓
20companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
1NIH grants · 2011–2015

Federally funded research awards.

View funding ↓

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 14 Oct 2026

Listed as an investigator on 5 registered studies on ClinicalTrials.gov. The most recent:

All 5 trial records: search, sort and filter.Explore →

Industry payments

Updated 14 Oct 2026

20 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

All 40 payment records: search, sort and filter.Explore →
View the CMS Open Payments record ↗

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Nervous system

    91.1%
    Aromatic Amino Acid Decarboxylation Inhibitor50.7%
    Carbidopa-Levodopa58%Rytary28%Carbidopa-Levodopa Er14%
    Part D<11 patients
    Benzodiazepine14.2%
    Clonazepam65%Alprazolam35%
    Part D<11 patients

    + 5 more classes in this area

  • Cardiovascular

    8.9%
    Beta blocker5%
    Propranolol Hcl Er100%
    Part D<11 patients
    Adrenergic and dopaminergic agents4%
    Northera100%
    Part D<11 patients
Where care is delivered (Part B)100% facility · 0% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

Updated 14 Oct 2026

1 NIH research award on record, funded 2011–2015 per NIH RePORTER. The latest:

All 5 award records: search, sort and filter.Explore →

Congress activity

Updated 14 Oct 2026

1 congress contribution (2017) across AMCP per OpenAlex. The most recent:

Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.

Publications

Updated 14 Oct 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

All 104 publications: search, sort and filter.Explore →

Most-cited works

by citation count (OpenAlex)
  1. 01
    Current Concepts in Diagnosis and Treatment of Functional Neurological Disorders
    758 citations2018
    doi.org ↗
  2. 02
    Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: a randomised, controlled, double-blind, double-dummy study
    698 citations2013
    doi.org ↗
  3. 03
    Technology in Parkinson's disease: Challenges and opportunities
    657 citations2016
    doi.org ↗
  4. 04
    Effects of admission hyperglycemia on mortality and costs in acute ischemic stroke
    483 citations2002
    doi.org ↗
  5. 05
    Disease Modification in Parkinson's Disease: Current Approaches, Challenges, and Future Considerations
    362 citations2018
    doi.org ↗
All 752 cited works: search, sort and filter.Explore →

Network

Updated 14 Oct 2026

The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.

Daniel Weintraub80Federico Rodríguez‐Porcel76Anthony E. Lang74Luca Marsili63Keith A. Josephs59Rhonna Shatz59Alfonso Fasano54Aristide Merola51Alok Dwivedi45Andrew P. Duker41Andrea Sturchio40Abhimanyu Mahajan34Francesca Morgante33Joaquín A. Vizcarra33Kevin R. Duque32Tanya Simuni30Marcelo Kauffman28Fredy J. Revilla27Stuart Isaacson23Benjamin Stecher23Leonardo Lopiano22Bastiaan R. Bloem21Robert A. Hauser21Susan H. Fox20Stewart A. Factor20Walter Maetzler20David G. Standaert19Alberto Romagnolo19Irene Litvan19Joel S. Perlmutter18James B. Leverenz18Hubert H. Fernandez18Brian D. Berman17Hyder A. Jinnah17Caroline M. Tanner17Kariem Ezzat16Mark Hallett16Rajesh Pahwa16Marie Vidailhet16Michael A. Schwarzschild16

Online presence

Updated 14 Oct 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • Doximity

    doximity.com/pub/alberto-espay-md

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗
  • LinkedIn

    linkedin.com/in/alberto-espay-9a834758

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗
  • ResearchGate

    researchgate.net/profile/Alberto-Espay

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗
  • ResearchGate

    researchgate.net/scientific-contributions/Alberto-J-Espay-2271793681

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗
  • X / Twitter

    x.com/AlbertoEspay

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →x.com ↗

Mentions by others

where others cite or feature them
  • Apple Podcasts

    podcasts.apple.com/us/podcast/alberto-espay-md-brain-fables/id1484074780

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →podcasts.apple.com ↗
  • Other

    michaeljfox.org/researcher/alberto-espay-md

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →michaeljfox.org ↗
  • YouTube

    youtube.com/watch

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →youtube.com ↗
  • YouTube

    youtube.com/watch

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →youtube.com ↗
  • LinkedIn

    LinkedIn: linkedin.com/in/alberto-espay-9a834758 (active professional posts on Parkinson's research)

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →linkedin.com ↗

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 14 Oct 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record
  • MSc in Clinical Epidemiology and Health Care Research

    University of Toronto

    2005
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchdirectory.uc.edu ↗
  • Fellowship in Electrophysiology of Movement Disorders

    Dystonia Medical Research Foundation, Chicago

    2005
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →uchealth.com ↗
  • Fellowship in Movement Disorders

    University of Toronto

    2003
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →uchealth.com ↗
  • Board Certified

    American Board of Psychiatry and Neurology (Neurology), certified 05-12-2003

    2003
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →uchealth.com ↗
  • Neurology Residency

    Indiana University

    2001
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →uchealth.com ↗
  • MD

    Central University of Venezuela (Caracas, Venezuela)

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchdirectory.uc.edu ↗
  • FAAN

    Fellow, American Academy of Neurology

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →researchgate.net ↗
  • FANA

    Fellow, American Neurological Association

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →discerntest.com ↗

Editorial & leadership roles

journal and society appointments
  • Associate Editor

    Movement Disorders (journal)

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →researchgate.net ↗
  • Chair

    Movement Disorders Section, American Academy of Neurology

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →researchgate.net ↗
  • President

    Pan-American Section of the International Parkinson and Movement Disorder Society

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →michaeljfox.org ↗
  • Associate Editor

    Frontiers in Movement Disorders

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →ucneuroscience.com ↗

Awards & honors

honors on the public record

Secondary affiliations

appointments beyond the home institution
  • Funded researcher

    Michael J. Fox Foundation for Parkinson's Research (grant: "Methylphenidate for the Treatment of Gait Impairment in Parkinson's Disease")

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →michaeljfox.org ↗
  • Executive Committee member

    Parkinson Study Group

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →researchgate.net ↗

Media & interviews

press, podcasts and appearances
  • TED Talk: "Parkinson's and Alzheimer's: The Solution in Sight" (Dr. Alberto Espay, TEDx)
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ted.com ↗
  • Podcast guest

    Parkinson's Foundation "Substantial Matters" Episode 59: Understanding Biomarkers to Deliver Precise Treatments

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →parkinson.org ↗
  • Podcast guest

    Behind the Microscope: "Alberto Espay, MD - Brain Fables" (Apple Podcasts)

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →podcasts.apple.com ↗
  • Podcast guest

    The Neurology Lounge Episode 6: In Conversation with Alberto Espay, Author of Brain Fables

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →theneurologylounge.com ↗
  • Video/news feature

    NeurologyLive: "Alberto Espay, MD, MSc: Modifying Thought About Parkinson Disease"

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →neurologylive.com ↗
  • Podcast guest

    No Silver Bullet: "The missing ingredient for successful disease modification"

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →buzzsprout.com ↗

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.